Retinal Sensitivity Loss Correlates with Deep Capillary Plexus Impairment in Diabetic Macular Ischemia

Table 1

Demographic and clinical findings of study population.

Case	Sex/age, years	Duration of DM	Study eye	BCVA	DR stage	Laser treatment	HbA1c
1	M/69	12 years	LE	20/20	PDR	PRP	10.2
2	M/55	16 years	LE	20/20	Severe NPDR	None	8.6
3	M/55	6 years	LE	20/25	Severe NPDR	None	7.8
4	M/68	15 years	RE	20/25	PDR	PRP	9.3
5	M/62	15 years	LE	20/25	Severe NPDR	None	6.7
6	M/62	12 years	RE	20/40	PDR	PRP	10.1
7	M/56	12 years	LE	20/20	Severe NPDR	None	7.6
8	M/48	3 years	RE	20/20	PDR	PRP	8.7
9	F/67	15 years	RE	20/25	PDR	PRP	9.4
10	M/59	10 years	RE, LE	20/40	PDR	PRP	9.7
11	F/64	9 years	RE	20/40	Severe NPDR	None	7.3
12	M/61	8 years	RE, LE	20/25	Severe NPDR	None	6.5

Abbreviations: F = female; M = male; DM = diabetes mellitus; HbA1c = hemoglobin A1c value; RE = right eye; LE = left eye; PDR = proliferative diabetic retinopathy; NPDR = nonproliferative diabetic retinopathy; BCVA = best-corrected visual acuity; PRP = panretinal photocoagulation.